NanoRepro AG (NN6.DE)

1.8400 0.0000 (0.00%) At close: 05:36PM CEST

NanoRepro AG

Untergasse 8
Marburg 35037
Germany
49 6421 951449
https://www.nanorepro.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 17

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Lisa Jungst	President of the Management Board & CEO	N/A	N/A	N/A
Mr. Stefan Pieh	CFO & Member of Management Board	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, such as family planning, and preventive healthcare line products; tests for hospitals and medical practices to detect aids, Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as SARS-CoV-2 antibody test and corona antigen rapid test. It also provides food supplements for men and women, including Alphabiol Beauty Elixier for the skin shine based on combination of micronutrients; Alphabiol Fertility for men; Alphabiol Curcumin Elixier mit Curcumin + Vitamin D, an essential nutrient for Vitamin D through online shops and pharmacies. The company was founded in 2006 and is headquartered in Marburg, Germany.

Corporate governance

NanoRepro AG’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.